(Q44114739)

29 November 2017

title

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis (English)

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

23 October 2022

0 references

0 references

1 reference

hepatocellular carcinoma

1 reference

1 reference

2

M. Romano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1658121

23 October 2022

author name string

de Sio I

4

1 reference

29 November 2017

N. Caporaso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1658121

23 October 2022

R. Marmo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1658121

23 October 2022

I. de Sio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1658121

23 October 2022

F. Morisco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1658121

23 October 2022

A. Minerva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1658121

23 October 2022

M. Coltorti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1658121

23 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1658121

23 October 2022

publication date

1 May 1991

1 reference

full work available at URL

29 November 2017

https://api.elsevier.com/content/article/PII:016882789190841X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

https://api.elsevier.com/content/article/PII:016882789190841X?httpAccept=text/plain

23 October 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

23 October 2022

published in

Journal of Hepatology

1 reference

29 November 2017

volume

12

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

367-371

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

29 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

23 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Hepatitis C virus: a possible cause of chronic hepatitis in alcoholics

23 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis

23 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis

23 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Changing incidence of hepatocellular carcinoma in Japan

23 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

23 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

23 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

23 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis

23 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

23 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Screening for hepatocellular carcinoma in high-risk individuals. A clinical review

23 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Primary liver cancers in Japan

23 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

23 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Risk factors for hepatocellular carcinoma in Northern Italy

23 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?

23 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma

23 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

23 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90841-X

23 October 2022

Identifiers

1 reference

29 November 2017

1 reference